Literature DB >> 10089737

[Mammographic screening does not reduce breast cancer mortality].

G Sjönell1, L Ståhle.   

Abstract

The outcome of a Swedish mammographic screening programme has been studied by analysis of official health statistics for 1987-96. The study series comprised 605,260 women (70 per cent of those aged 50-69 years at inclusion in the mammography programme), representing 4,908,176 woman-years, 1,932,353 mammographies, and 6,713 deaths due to breast cancer. The observed number of deaths was 55 (0.8%) less than would have been expected had the screening not been performed (ns), whereas findings in the Two County Council study suggest that the reduction in mortality should have been 28 per cent (n = 739) for the group and period studied. Thus, the cost of saving a single life was estimated to have been SEK 18-25 million (approximately GBP 1.3(1.8 m. USD 2.36(3.17 m).

Entities:  

Mesh:

Year:  1999        PMID: 10089737

Source DB:  PubMed          Journal:  Lakartidningen        ISSN: 0023-7205


  6 in total

1.  Breast screening. No need to reconsider breast screening programme on basis of results from defective study.

Authors:  M Rosén; N Rehnqvist
Journal:  BMJ       Date:  1999-03-20

2.  How effective is screening for breast cancer?

Authors:  L Nyström
Journal:  BMJ       Date:  2000-09-16

3.  The politicians' perspectives on participation in mammographic screening: an interview-based study from a region in Sweden.

Authors:  Maria Norfjord van Zyl; Per Tillgren; Margareta Asp
Journal:  Arch Public Health       Date:  2021-04-17

4.  A Saga-In-Progress: Challenges and Milestones on Our Way Toward the Nordic Core Values and Principles of Family Medicine/General Practice.

Authors:  Johann A Sigurdsson; Anders Beich; Anna Stavdal
Journal:  Front Med (Lausanne)       Date:  2021-11-26

Review 5.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2009-07-09

6.  Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia.

Authors:  J McCann; S Duffy; N Day
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.